Patent Ductus Arteriosus - 26 Studies Found
Terminated |
: An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants : Patent Ductus Arteriosus : 2008-09-08 : Drug: Indomethacin Infants randomized to Escalating Dose group will receive indomethacin (0.2 mg/kg/dose |
Recruiting |
: Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI) : Patent Ductus Arteriosus : 2012-06-11 :
|
Recruiting |
: Treating the Resistant Patent Ductus Arteriosus (PDA) : Patent Ductus Arteriosus : 2008-01-13 :
|
Completed |
: Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus : Patent Ductus Arteriosus : 2012-05-03 :
|
Not yet recruiting |
: IV Acetaminophen and Patent Ductus Arteriosus : Patent Ductus Arteriosus : 2016-12-30 :
|
Not yet recruiting |
: Paracetamol and Patent Ductus Arteriosus (PDA) : Patent Ductus Arteriosus : 2011-02-06 :
|
Completed |
: Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus : Patent Ductus Arteriosus : 2005-09-10 : Drug: indomethacin (two different dosing regimens) |
Completed |
: Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants : Patent Ductus Arteriosus : 2012-12-16 : Drug: Ibuprofen To compare the efficacy, the side effects and the renal prostaglandin (PG) excretion bet |
Completed |
: Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants : Patent Ductus Arteriosus : 2008-11-20 |
Recruiting |
: Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure : Patent Ductus Arteriosus : 2017-01-18 : Device: near infrared spectroscopy Near infrared spectroscopy will be placed on infants both with and wi |